Advertisement

Nederlands Tijdschrift voor Diabetologie

, Volume 13, Issue 3, pp 62–62 | Cite as

9. Effects of Sensor Augmented Pump Use on HbA1c and C-Peptide in the First Year of Type 1 Diabetes (355-OR)

  • Taylor M. Triolo
  • David M. Maahs
  • Peiyao Cheng
  • Laura Pyle
  • Bruce A. Buckingham
  • Robert Slover
  • H. Peter Chase
Congresverslag
  • 88 Downloads

Samenvatting

Intensive control after onset of type 1 diabetes (T1D) has been suggested to preserve C-peptide production. Subjects with T1D used a sensor-augmented pump (SAP), after 3 days of in hospital hybrid closed loop or usual care. In the primary intent to treat analysis (Buckingham, Diabetes Care, 2013) there were no significant differences in HbA1c or in C-peptide between the two groups at 1 year. In this post-hoc analysis, we hypothesized that more frequent CGM use would be associated with lower HbA1c and preservation of C-peptide production in the SAP group. Subjects in the SAP group (n = 48) were stratified by median CGM use. HbA1c and C-peptide were compared at baseline 3, 6, 9 and 12 months.

Literatuur

  1. 1.
    Buckingham B, Beck RW, Ruedy KJ, Cheng P, Kollman C, Weinzimer SA et al. Effectiveness of early intensive therapy on β-cell preservation in type 1 diabetes. Diabetes Care. 2013 Dec;36(12):4030-5.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Bohn Stafleu van Loghum 2015

Authors and Affiliations

  • Taylor M. Triolo
    • 1
  • David M. Maahs
    • 1
  • Peiyao Cheng
    • 1
  • Laura Pyle
    • 1
  • Bruce A. Buckingham
    • 1
  • Robert Slover
    • 1
  • H. Peter Chase
    • 1
  1. 1.

Personalised recommendations